4-142108117-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_001101669.3(INPP4B):​c.2350T>G​(p.Phe784Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

INPP4B
NM_001101669.3 missense

Scores

9
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.96
Variant links:
Genes affected
INPP4B (HGNC:6075): (inositol polyphosphate-4-phosphatase type II B) INPP4B encodes the inositol polyphosphate 4-phosphatase type II, one of the enzymes involved in phosphatidylinositol signaling pathways. This enzyme removes the phosphate group at position 4 of the inositol ring from inositol 3,4-bisphosphate. There is limited data to suggest that the human type II enzyme is subject to alternative splicing, as has been established for the type I enzyme. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INPP4BNM_001101669.3 linkc.2350T>G p.Phe784Val missense_variant Exon 23 of 26 ENST00000262992.9 NP_001095139.1 O15327-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INPP4BENST00000262992.9 linkc.2350T>G p.Phe784Val missense_variant Exon 23 of 26 5 NM_001101669.3 ENSP00000262992.4 O15327-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
25
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 27, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.2350T>G (p.F784V) alteration is located in exon 24 (coding exon 20) of the INPP4B gene. This alteration results from a T to G substitution at nucleotide position 2350, causing the phenylalanine (F) at amino acid position 784 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
0.0048
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.60
D;D;D;T;T;.;T
Eigen
Benign
0.0054
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.95
.;D;.;D;D;D;D
M_CAP
Benign
0.013
T
MetaRNN
Uncertain
0.56
D;D;D;D;D;D;D
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L;L;L;.;.;.;.
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-4.3
D;D;D;D;D;D;D
REVEL
Benign
0.15
Sift
Uncertain
0.0080
D;D;D;D;D;T;T
Sift4G
Uncertain
0.011
D;D;D;D;.;.;D
Polyphen
0.0040
B;B;B;.;.;.;.
Vest4
0.63
MutPred
0.65
Gain of catalytic residue at F784 (P = 0.0208);Gain of catalytic residue at F784 (P = 0.0208);Gain of catalytic residue at F784 (P = 0.0208);Gain of catalytic residue at F784 (P = 0.0208);.;Gain of catalytic residue at F784 (P = 0.0208);.;
MVP
0.46
MPC
0.27
ClinPred
0.99
D
GERP RS
4.4
Varity_R
0.31
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr4-143029270; API